Latest Cas Medical Systems (CASM) Headlines
CASMED Announces Fourth Quarter and Full-Year 2013 Financial Results
GlobeNewswire - Thu Mar 06, 8:24AM CST
Fourth Quarter U.S. FORE-SIGHT(R) Disposable Sales Increase 35%
CASMED to Present at 26th Annual ROTH Conference
GlobeNewswire - Wed Feb 26, 7:42AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that Thomas M. Patton, President and Chief Executive Officer, will present at the 26th Annual ROTH Conference on Tuesday, March 11, 2014, at 3:00 p.m. PT. The conference is being held at The Ritz Carlton in Dana Point, California, from March 9 to March 12.
CASMED to Announce Fourth Quarter and Full-Year 2013 Financial Results and Hold Conference Call on March 6
GlobeNewswire - Tue Feb 25, 7:10AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announced today that it will report financial results for the fourth quarter and full-year 2013 on Thursday, March 6, 2014, prior to the market's opening. Management will host a conference call to discuss these results and answer questions at 10:00 A.M. (ET) that day.
2013 Report on the International Capnography Market 2012 - Forecasts to 2016
M2 - Mon Jan 13, 4:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/g7h4gv/global) has announced the addition of the "2013 Report on the International Capnography Market 2012 - Forecasts to 2016" report to their offering. Advancements in capnography technology are allowing critical care providers to have a more accurate way of measuring CO2 in critical care patients. Although healthcare professionals have experienced major difficulties and limitations when using Mainstream and Sidestream capnography over the past few years, the latest Microstream capnography technology is expected to overcome those drawbacks. Microstream technology helps care providers monitor both intubated and non-intubated patients. Devices based on this technology can operate in extremely humid environments, in homecare, ambulatory services, and in hospitals. Microstream devices also offer improved moisture management to eliminate problems caused by blocked sample lines. One of the major growth drivers is the tremendous advancements in technology being made in the form of innovations that have led to the development of new-generation capnography devices. For example, Oridion's Microstream technology created a revolution in the Global Capnography market. Moreover, potential users in the APAC region are also expected to boost the market during the forecast period. These factors in combination with others are expected to drive the growth of the Global Capnography market during the forecast period. The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are CAS Medical Systems Inc., Diamedica Inc., Dragerwerk AG & Co. KGaA, GE Healthcare Ltd., Ivy Biomedical Systems Inc., Medtronic Inc., Nihon Kohden Corp. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Key Leading Countries 9. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis Companies Mentioned: - CAS Medical Systems - Covidien - Diamedica - Dragerwerk AG & Co. KGaA - GE Healthcare - Ivy Biomedical Systems - Medtronic - Nihon Kohden - Nonin Medical - OSI Systems - Opto Circuits (India) - Philips Healthcare - Smiths Medical - Triton Electronics - Weinmann Gerate fur Medizin - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/g7h4gv/global
Nasdaq stocks posting largest volume increases
AP - Wed Jan 08, 5:15PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
CASMED Reports Preliminary Sales for Fourth Quarter and Full Year 2013
GlobeNewswire - Wed Jan 08, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported preliminary top-line unaudited results for the fourth quarter and full year 2013.
Gitga'at First Nation Disappointed in Joint Review Panel Recommendation; Hopes Federal Government Will Reject Enbridge's Northern Gateway Project
Marketwire Canada - Thu Dec 19, 4:56PM CST
The Gitga'at First Nation is disappointed in the Joint Review Panel's recommendation on the Northern Gateway project, but is hopeful the Federal government will reject the project as inconsistent with its constitutional and international legal obligations to respect the rights of Aboriginal peoples and in the interest of building positive relationships with the Gitga'at and other BC First Nations.
CASMED Places 900th FORE-SIGHT(R) Cerebral Oximeter
GlobeNewswire - Tue Dec 03, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that the worldwide installed base of its FORE-SIGHT Cerebral Oximeters surpassed 900 in November. The installed base includes seven of the top 20 adult cardiac surgery centers and three of the top ten pediatric centers in the U.S. The Company had previously disclosed an installed base of 845 units as of September 30, 2013.
CASMED Receives China Food and Drug Administration Approval for FORE-SIGHT(R) Cerebral Oximeter
GlobeNewswire - Mon Nov 25, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that its FORE-SIGHT Cerebral Oximeter has been approved by the China Food and Drug Administration (CFDA) for sale in that country. FORE-SIGHT is the only cerebral oximeter manufactured outside China to have approval from the CDFA.
CASMED to Present at the LD MICRO MAIN EVENT Conference
GlobeNewswire - Thu Nov 21, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that Thomas M. Patton, President and Chief Executive Officer, will present at the sixth annual LD MICRO conference on Tuesday, December 3, 2013, at 3:30 p.m. Pacific time. The conference will be held at the Luxe Sunset Hotel in Los Angeles.
CASMED Announces Third Quarter 2013 Financial Results
GlobeNewswire - Tue Nov 12, 7:00AM CST
Launch of Next-Generation Cerebral Oximetry Products Underway
Global Multiparameter Patient Monitoring Equipment Market 2012-2016 with Omron Healthcare Co. Ltd., Philips Healthcare, and Spacelabs Healthcare Inc. Dominating
M2 - Mon Nov 11, 10:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/hh7xr4/global) has announced the addition of the "Global Multiparameter Patient Monitoring Equipment Market 2012-2016" report to their offering. The analysts forecast the Global Multiparameter Patient Monitoring Equipment market to grow at a CAGR of 3.53 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growth in aging population. The Global Multiparameter Patient Monitoring Equipment market has also been witnessing technological advancements. However, the high price and low accuracy of remote patient monitoring Systems could pose a challenge to the growth of this market. The key vendors dominating this market space are Draegerwerk AG & Co. KGaA, GE Healthcare, Omron Healthcare Co. Ltd., Philips Healthcare, and Spacelabs Healthcare Inc. Other vendors mentioned in the report are A&D Company Ltd., CAS Medical Systems Inc., Contec Medical Systems Co. Ltd., Edwards Lifesciences Corp., GE Healthcare Ltd., Johnson & Johnson, Larsen & Toubro Ltd., and Schiller AG. Commenting on the report, an analyst from the team said: The increased focus on R&D has introduced multiparameter monitoring devices with advanced measuring capabilities, offering cost-effective solutions. For instance, various parameters, such as depth analysis of anesthesia, invasive blood pressure, spirometer, and cardiac output, are being incorporated into the monitoring devices. Additionally, there has been an integration of remote-control functionality and alarm management functions into these monitoring devices to increase patient safety. Further, monitors with intuitive touchscreen and clear display, and one-touch command are being introduced to enable ease of use. Thus, increase in technological advancement is expected to drive the Global Multiparameter Patient Monitoring Equipment market during the forecast period. According to the report, one of the major drivers is the increased growth in aging population. The increasing aging population is contributing to the growth of the Global Multiparameter Patient Monitoring Equipment market. Multiparameter patient monitors enable faster detection and monitoring of critical illnesses. The number of patients suffering from critical diseases is growing, owing to the increasing aging population, both in the developing and developed nations. For more information visit http://www.researchandmarkets.com/research/hh7xr4/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CASMED to Announce Third Quarter 2013 Financial Results and Hold Conference Call on November 12
GlobeNewswire - Wed Oct 30, 7:01AM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced it will report financial results for the third quarter of 2013 on Tuesday, November 12, 2013, prior to the market's opening. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. (ET) that day.
CASMED to Exhibit FORE-SIGHT ELITE(TM) Cerebral Oximeter at American Society of Anesthesiologists Meeting October 12-16 in San Francisco
GlobeNewswire - Fri Oct 11, 11:26AM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, is exhibiting its next generation FORE-SIGHT ELITE(TM) Cerebral Oximetry product at the American Society of Anesthesiologists (ASA) Annual Meeting, being held October 12-16, 2013, at the Moscone Center in San Francisco. Company representatives will be on hand at Booth No. 1027 to demonstrate the improved features and benefits of the ELITE.
CASMED Announces Initial Sales of the Next-Generation FORE-SIGHT ELITE Cerebral Oximeter
GlobeNewswire - Thu Sep 12, 3:05PM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced it recently recorded the first commercial sale of its next generation FORE-SIGHT ELITE(TM) Cerebral Oximetry products. The Company received U.S. Food and Drug Administration (FDA) clearance for the ELITE in mid-April and began a controlled product introduction in August with select customers for evaluation purposes.
CASMED Announces Second Quarter 2013 Financial Results
GlobeNewswire - Wed Aug 07, 7:00AM CDT
Launch of Next-Generation Vital Signs Monitor Underway
CASMED to Announce Second Quarter 2013 Financial Results and Hold Conference Call on August 7
GlobeNewswire - Tue Jul 30, 7:00AM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED) a leader in medical devices for non-invasive patient monitoring, today announced it will report financial results for the second quarter of 2013 on Wednesday, August 7, 2013 prior to the market's opening. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. (ET) that day.
CASMED Announces Fourth Quarter and Full-Year 2013 Financial Results
GlobeNewswire - Thu Mar 06, 8:24AM CST
Fourth Quarter U.S. FORE-SIGHT(R) Disposable Sales Increase 35%
CASMED to Present at 26th Annual ROTH Conference
GlobeNewswire - Wed Feb 26, 7:42AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that Thomas M. Patton, President and Chief Executive Officer, will present at the 26th Annual ROTH Conference on Tuesday, March 11, 2014, at 3:00 p.m. PT. The conference is being held at The Ritz Carlton in Dana Point, California, from March 9 to March 12.
CASMED to Announce Fourth Quarter and Full-Year 2013 Financial Results and Hold Conference Call on March 6
GlobeNewswire - Tue Feb 25, 7:10AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announced today that it will report financial results for the fourth quarter and full-year 2013 on Thursday, March 6, 2014, prior to the market's opening. Management will host a conference call to discuss these results and answer questions at 10:00 A.M. (ET) that day.
2013 Report on the International Capnography Market 2012 - Forecasts to 2016
M2 - Mon Jan 13, 4:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/g7h4gv/global) has announced the addition of the "2013 Report on the International Capnography Market 2012 - Forecasts to 2016" report to their offering. Advancements in capnography technology are allowing critical care providers to have a more accurate way of measuring CO2 in critical care patients. Although healthcare professionals have experienced major difficulties and limitations when using Mainstream and Sidestream capnography over the past few years, the latest Microstream capnography technology is expected to overcome those drawbacks. Microstream technology helps care providers monitor both intubated and non-intubated patients. Devices based on this technology can operate in extremely humid environments, in homecare, ambulatory services, and in hospitals. Microstream devices also offer improved moisture management to eliminate problems caused by blocked sample lines. One of the major growth drivers is the tremendous advancements in technology being made in the form of innovations that have led to the development of new-generation capnography devices. For example, Oridion's Microstream technology created a revolution in the Global Capnography market. Moreover, potential users in the APAC region are also expected to boost the market during the forecast period. These factors in combination with others are expected to drive the growth of the Global Capnography market during the forecast period. The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are CAS Medical Systems Inc., Diamedica Inc., Dragerwerk AG & Co. KGaA, GE Healthcare Ltd., Ivy Biomedical Systems Inc., Medtronic Inc., Nihon Kohden Corp. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Key Leading Countries 9. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis Companies Mentioned: - CAS Medical Systems - Covidien - Diamedica - Dragerwerk AG & Co. KGaA - GE Healthcare - Ivy Biomedical Systems - Medtronic - Nihon Kohden - Nonin Medical - OSI Systems - Opto Circuits (India) - Philips Healthcare - Smiths Medical - Triton Electronics - Weinmann Gerate fur Medizin - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/g7h4gv/global
Nasdaq stocks posting largest volume increases
AP - Wed Jan 08, 5:15PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
CASMED Reports Preliminary Sales for Fourth Quarter and Full Year 2013
GlobeNewswire - Wed Jan 08, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported preliminary top-line unaudited results for the fourth quarter and full year 2013.
Gitga'at First Nation Disappointed in Joint Review Panel Recommendation; Hopes Federal Government Will Reject Enbridge's Northern Gateway Project
Marketwire Canada - Thu Dec 19, 4:56PM CST
The Gitga'at First Nation is disappointed in the Joint Review Panel's recommendation on the Northern Gateway project, but is hopeful the Federal government will reject the project as inconsistent with its constitutional and international legal obligations to respect the rights of Aboriginal peoples and in the interest of building positive relationships with the Gitga'at and other BC First Nations.
CASMED Places 900th FORE-SIGHT(R) Cerebral Oximeter
GlobeNewswire - Tue Dec 03, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that the worldwide installed base of its FORE-SIGHT Cerebral Oximeters surpassed 900 in November. The installed base includes seven of the top 20 adult cardiac surgery centers and three of the top ten pediatric centers in the U.S. The Company had previously disclosed an installed base of 845 units as of September 30, 2013.
CASMED Receives China Food and Drug Administration Approval for FORE-SIGHT(R) Cerebral Oximeter
GlobeNewswire - Mon Nov 25, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that its FORE-SIGHT Cerebral Oximeter has been approved by the China Food and Drug Administration (CFDA) for sale in that country. FORE-SIGHT is the only cerebral oximeter manufactured outside China to have approval from the CDFA.
CASMED to Present at the LD MICRO MAIN EVENT Conference
GlobeNewswire - Thu Nov 21, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that Thomas M. Patton, President and Chief Executive Officer, will present at the sixth annual LD MICRO conference on Tuesday, December 3, 2013, at 3:30 p.m. Pacific time. The conference will be held at the Luxe Sunset Hotel in Los Angeles.
CASMED Announces Third Quarter 2013 Financial Results
GlobeNewswire - Tue Nov 12, 7:00AM CST
Launch of Next-Generation Cerebral Oximetry Products Underway
Global Multiparameter Patient Monitoring Equipment Market 2012-2016 with Omron Healthcare Co. Ltd., Philips Healthcare, and Spacelabs Healthcare Inc. Dominating
M2 - Mon Nov 11, 10:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/hh7xr4/global) has announced the addition of the "Global Multiparameter Patient Monitoring Equipment Market 2012-2016" report to their offering. The analysts forecast the Global Multiparameter Patient Monitoring Equipment market to grow at a CAGR of 3.53 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growth in aging population. The Global Multiparameter Patient Monitoring Equipment market has also been witnessing technological advancements. However, the high price and low accuracy of remote patient monitoring Systems could pose a challenge to the growth of this market. The key vendors dominating this market space are Draegerwerk AG & Co. KGaA, GE Healthcare, Omron Healthcare Co. Ltd., Philips Healthcare, and Spacelabs Healthcare Inc. Other vendors mentioned in the report are A&D Company Ltd., CAS Medical Systems Inc., Contec Medical Systems Co. Ltd., Edwards Lifesciences Corp., GE Healthcare Ltd., Johnson & Johnson, Larsen & Toubro Ltd., and Schiller AG. Commenting on the report, an analyst from the team said: The increased focus on R&D has introduced multiparameter monitoring devices with advanced measuring capabilities, offering cost-effective solutions. For instance, various parameters, such as depth analysis of anesthesia, invasive blood pressure, spirometer, and cardiac output, are being incorporated into the monitoring devices. Additionally, there has been an integration of remote-control functionality and alarm management functions into these monitoring devices to increase patient safety. Further, monitors with intuitive touchscreen and clear display, and one-touch command are being introduced to enable ease of use. Thus, increase in technological advancement is expected to drive the Global Multiparameter Patient Monitoring Equipment market during the forecast period. According to the report, one of the major drivers is the increased growth in aging population. The increasing aging population is contributing to the growth of the Global Multiparameter Patient Monitoring Equipment market. Multiparameter patient monitors enable faster detection and monitoring of critical illnesses. The number of patients suffering from critical diseases is growing, owing to the increasing aging population, both in the developing and developed nations. For more information visit http://www.researchandmarkets.com/research/hh7xr4/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CASMED to Announce Third Quarter 2013 Financial Results and Hold Conference Call on November 12
GlobeNewswire - Wed Oct 30, 7:01AM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced it will report financial results for the third quarter of 2013 on Tuesday, November 12, 2013, prior to the market's opening. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. (ET) that day.
CASMED to Exhibit FORE-SIGHT ELITE(TM) Cerebral Oximeter at American Society of Anesthesiologists Meeting October 12-16 in San Francisco
GlobeNewswire - Fri Oct 11, 11:26AM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, is exhibiting its next generation FORE-SIGHT ELITE(TM) Cerebral Oximetry product at the American Society of Anesthesiologists (ASA) Annual Meeting, being held October 12-16, 2013, at the Moscone Center in San Francisco. Company representatives will be on hand at Booth No. 1027 to demonstrate the improved features and benefits of the ELITE.
CASMED Announces Initial Sales of the Next-Generation FORE-SIGHT ELITE Cerebral Oximeter
GlobeNewswire - Thu Sep 12, 3:05PM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced it recently recorded the first commercial sale of its next generation FORE-SIGHT ELITE(TM) Cerebral Oximetry products. The Company received U.S. Food and Drug Administration (FDA) clearance for the ELITE in mid-April and began a controlled product introduction in August with select customers for evaluation purposes.
CASMED Announces Second Quarter 2013 Financial Results
GlobeNewswire - Wed Aug 07, 7:00AM CDT
Launch of Next-Generation Vital Signs Monitor Underway
CASMED to Announce Second Quarter 2013 Financial Results and Hold Conference Call on August 7
GlobeNewswire - Tue Jul 30, 7:00AM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED) a leader in medical devices for non-invasive patient monitoring, today announced it will report financial results for the second quarter of 2013 on Wednesday, August 7, 2013 prior to the market's opening. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. (ET) that day.
